PROVON® Perineal Wash

8 fl oz Spray Bottle

PROVON® Perineal Wash
How To Buy

0 | 0 Reviews

SKU: 4525-48
Size: 8 fl oz
SDS Downloads English English Spanish

PROVON® Perineal Wash

8 fl oz Spray Bottle

Gentle, no rinse alternative to soap and water.

  • Specially formulated for use on delicate skin
  • Fast-acting formulation
  • Contains vitamin E and aloe
How To Buy

0 | 0 Reviews

SKU: 4525-48
Size: 8 fl oz
SDS Downloads English English Spanish
SKU
4525-48
Size
8 fl oz
Case Pack
48
Case Weight
29.1 lbs
Overall Case Dimensions
15.81 h x 8.47 w x 12.59 d
Overall Unit Dimensions
7.52 h x 2.01 w x 2.01 l
Case Cu. Ft.
0.93 Inches
Cases Per Layer
16
Cases Per Pallet
48
Layers Per Pallet
3
Product Type Packaging
Bottles
Country of Manufacture
United States
UPC (Each)
073852019834
Case UPC (GTIN)
10073852019831

1. Remove excess fecal matter.

2. Apply product to warm damp wash cloth(s).

3. Gently clean entire perineal area, always wiping from front to back.

4. Repeat with additional washcloths as needed.

Reducing Infection Rates in Healthcare

Bacterial shedding and desquamation from the hands of healthcare workers correlates with skin condition.


Read the article

Results: Bacterial dispersal and quantitative skin measurements were obtained from 86 healthcare workers over a 3 day period. The levels of bacteria shed from the hands of the healthcare workers was found to be negatively correlated to corneometer measurements (p < 0.01); and positively correlated to desquamation index (p < 0.02). No correlation was found between levels of shed bacteria and transepidermal water loss. As expected, corneometer measurements were found to be negatively correlated to desquamation index (p < 0.0001).
Conclusion: The results of this hospital study demonstrate that the levels of bacteria shed from the hands of healthcare workers are influenced by the health of the individual's skin; i.e. dry skin sheds more bacteria. This increased bacterial dispersal from dry skin may increase the infection transfer risk for healthcare workers with poor skin condition in the acute care setting.
Reference: American Journal of Infection Control, Volume 34, Issue 5, June 2006, Pages E85-E86. C.A. Kolly, J.W. Arbogast, D.R. Macinga